Format

Send to

Choose Destination
See comment in PubMed Commons below
J Geriatr Oncol. 2014 Jul;5(3):266-75. doi: 10.1016/j.jgo.2014.02.003. Epub 2014 Mar 5.

Long-term outcomes among African-American and white women with breast cancer: what is the impact of comorbidity?

Author information

1
Department of Epidemiology and Biostatistics, University of California, San Francisco, CA, USA.
2
School of Public Health, University of California, Berkeley, CA, USA.
3
Department of Community Health Sciences, Brock University, St. Catharines, Ontario, Canada.
4
Division of Hematology-Oncology, David Geffen School of Medicine, University of California, Los Angeles, CA, USA.
5
Department of Epidemiology and Biostatistics, University of California, San Francisco, CA, USA; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, CA, USA.
6
Department of Epidemiology and Biostatistics, University of California, San Francisco, CA, USA; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, CA, USA. Electronic address: DBraithwaite@epi.ucsf.edu.

Abstract

OBJECTIVES:

We examined the association between comorbidity and long-term mortality from breast cancer and other causes among African-American and white women with breast cancer.

METHODS:

A total of 170 African-American and 829 white women aged 40-84years were followed for up to 28years with median follow-up of 11.3years in the Health and Functioning in Women (HFW) study. The impact of the Charlson Comorbidity Score (CCS) in the first few months following breast cancer diagnosis on the risk of mortality from breast cancer and other causes was examined using extended Cox models.

RESULTS:

Median follow-up was significantly shorter for African-American women than their white counterparts (median 8.5years vs. 12.3years). Compared to white women, African-American women had significantly fewer years of education, greater body mass index, were more likely to have functional limitations and later stage at breast cancer diagnosis, and fewer had adequate financial resources (all P<0.05). Proportionately more African-American women died of breast cancer than white women (37.1% vs. 31.4%, P=0.15). A positive and statistically significant time-varying effect of the Charlson Comorbidity Score (CCS) on other-cause mortality persisted throughout the first 5years of follow-up (P<0.001) but not for its remainder.

CONCLUSIONS:

Higher CCS was associated with increased risk of other-cause mortality, but not breast cancer specific mortality; the association did not differ among African-American and white women.

KEYWORDS:

Breast cancer; Cohort study; Comorbidity; Mortality; Racial disparity; Survival

PMID:
24613574
DOI:
10.1016/j.jgo.2014.02.003
[Indexed for MEDLINE]
Free full text
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science Icon for eScholarship, California Digital Library, University of California
    Loading ...
    Support Center